Atlas Trials

Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

Clinical trial NCT00022594 · COMPLETED

Trial details

NCT number
NCT00022594
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2001-05-01
Primary completion
2002-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.